View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

HHS/OIG RIN: 0936-AA10 Publication ID: Fall 2019 
Title: Revisions to the Safe Harbors Under the Anti-Kickback Statute and Beneficiary Inducements Civil Monetary Penalties Rules Regarding Beneficiary Inducement  
Abstract:

This proposed rule is being issued by the Office of Inspector General (OIG) in conjunction with the Department of Health and Human Services’ Regulatory Sprint to Coordinated Care.  It proposes to add safe harbor protections under the Federal anti-kickback statute for certain coordinated care and associated value-based arrangements between or among clinicians, providers, suppliers, and others that squarely meet all safe harbor conditions.  It also would add protections under the anti-kickback statute and civil monetary penalty (CMP) law that prohibits inducements offered to patients for certain patient engagement and support arrangements to improve quality of care, health outcomes, and efficiency of care delivery that squarely meet all safe harbor conditions. The proposed rule also proposes modifications to some existing safe harbors and codification of new statutory safe harbors and CMP exceptions.

 
Agency: Department of Health and Human Services(HHS)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: No  Unfunded Mandates: No 
EO 13771 Designation: Fully or Partially Exempt 
CFR Citation: 42 CFR 1001.952    42 CFR 1003.110   
Legal Authority: Bipartisan Budget Act of 2018 (BBA, Pub. L. No. 115-123), secs. 50341 and 50412    sec. 1128D(b) of the Social Security Act and sec. 102 of the Social Security Act   
Legal Deadline:  None

Statement of Need:

The Department has identified the broad reach of the Federal anti-kickback statute and beneficiary inducements CMP as potentially inhibiting beneficial arrangements that would advance the ability of providers, suppliers, and others to transition more effectively and efficiently to value-based care and to better coordinate care among providers, suppliers, and others in both the Federal health care programs and commercial sectors.  To the extent providers are discouraged from entering into innovative arrangements, patient care may not be provided as efficiently as possible.  In addition, the potential consequences of noncompliance with these statutes may impede the ability of providers, suppliers, and others, including small providers and suppliers or those serving rural or medically underserved populations, to raise capital to invest in the transition to value-based care or to obtain infrastructure necessary to coordinate patient care, including technology.  This proposed rule attempts to address these concerns by removing unnecessary impediments to the transformation of the healthcare system into one that better pays for and delivers value.

Summary of the Legal Basis:

  • Section 1128B of the Act, the anti-kickback statue;
  • Section 205 of HIPAA established section 1128D of the Act (42 U.S.C. 1320a-7d), which includes criteria for modifying and establishing safe harbors under the anti-kickback statute;
  • Section 1128A(a)(5) of the Act sets forth civil monetary penalties for prohibited beneficiary inducements and section 1128A(i)(6) defines "remuneration";
  • We proposed to amend the definition of "remuneration"in the CMP rules at 42 CFR 1003.110.

 

Alternatives:

We considered both more restrictive and less restrictive proposals. We considered whether we could achieve the same results by modifying existing safe harbors rather than establishing a new framework for coordinated and value-based arrangements. We also considered not using the value-based framework for several of the proposed safe harbors, but we concluded that the fraud and abuse risks of protecting arrangements without the guardrails created by the value-based framework were too high.

Anticipated Costs and Benefits:

There are no significant costs associated with the proposed regulatory revisions that would impose any mandates on State, local or Tribal Governments or on the private sector.

Risks:

It is a challenge to predict the effects of this regulatory action in a rapidly evolving and diverse healthcare ecosystem of substantial innovation, experimentation, and deployment of technology and digital data. Our goal is to finalize safe harbors that protect arrangements that foster beneficial arrangements and promote value, while also protecting programs and beneficiaries against harms caused by fraud and abuse.

Timetable:
Action Date FR Cite
Request for Information  08/27/2018  83 FR 43607   
Request for Information Comment Period End  10/26/2018 
NPRM  10/17/2019  84 FR 55694   
NPRM Comment Period End  12/31/2019 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: Yes 
RIN Data Printed in the FR: No 
Agency Contact:
Meredith Williams
Senior Counsel
Department of Health and Human Services
Office of the Inspector General
330 Independence Avenue SW,
Washington, DC 20201
Phone:202 619-2580
Email: meredith.williams@oig.hhs.gov